Joseph A Macchiaroli, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7000 |
Dr. Tolutope O Ozah, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7000 |
Ramesh M Nayak, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7000 |
Kenneth R Noel, MD Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 881 Hospital Rd, Center For Pain Management, Indiana, PA 15701 Phone: 724-357-8135 Fax: 724-357-8138 |
Ronald L Jasper, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7000 |
Dr. Arie Kandel, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Road, Indiana, PA 15701 Phone: 724-357-7000 Fax: 412-831-5663 |
Adeniran A Haastrup, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7000 |
James E Mulac, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 Hospital Rd, Indiana, PA 15701 Phone: 724-357-7000 |
News Archive
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that EDARBI, an angiotensin II receptor blocker approved for the treatment of hypertension, or high blood pressure, is now available by prescription for adults in U.S. pharmacies.
Research staff from the Universitat Jaume I in the fields of information technology, psychology and business have developed a monitoring system based on indoor location using mobile devices.
A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of U.S. patent claims related to the Company's method of treating glioblastoma multiforme (GBM) in a patient by targeting cancer stem cells.
› Verified 4 days ago